Cargando…
Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study
Androgenetic alopecia (AGA) is the most common cause of hair loss in both genders with a higher psychological impact on females. Currently, topical minoxidil is the only FDA-approved treatment for female AGA and it needs life-long application and causes side effects. Cetirizine is an antihistamine t...
Autores principales: | Bassiouny, Eglal A., El-Samanoudy, Solwan I., Abbassi, Maggie M., Nada, Hanan R., Farid, Samar F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205881/ https://www.ncbi.nlm.nih.gov/pubmed/36571611 http://dx.doi.org/10.1007/s00403-022-02512-2 |
Ejemplares similares
-
Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia
por: Shadi, Zari
Publicado: (2023) -
A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
por: Shah, Kaksha B, et al.
Publicado: (2017) -
A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia
por: Kumar, Muriki K., et al.
Publicado: (2018) -
New Target for Minoxidil in the Treatment of Androgenetic Alopecia
por: Shen, Yuqing, et al.
Publicado: (2023) -
Scalp vascularization as a marker of topical minoxidil treatment efficacy in patients with androgenetic alopecia
por: Kozicka, Karolina, et al.
Publicado: (2021)